12 Alzheimers Disease Clinical Trials in New Brunswick, NJ (2026)

Q: How do I join a clinical trial in New Brunswick?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you.

Recruiting Alzheimers Disease Studies in New Brunswick

NCT07144319Recruiting

Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

Blue light cystoscopy (BLC) is a diagnostic procedure in bladder cancer where the inside of the bladder is observed with a camera to detect bladder lesions. Unlike regular white light cystoscopy, blue...

New Brunswick, NJ500 participantsPhotocure

View Study Details

NCT05581004Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

This is a first-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of enzelkitug when administered as a single agent and in combination with atezolizum...

New Brunswick, NJPHASE1450 participantsGenentech, Inc.

View Study Details

NCT06032559Recruiting

Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment

This hybrid implementation-effectiveness trial will evaluate Mindfulness-Oriented Recovery Enhancement (MORE) for patients with opioid use disorder receiving methadone treatment (MT). The investigator...

New Brunswick, NJPHASE3450 participantsRutgers, The State University of New Jersey

View Study Details

NCT05932862Recruiting

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

This is a first-in-human (FIH), multicenter, open-label Phase I study to investigate the safety, tolerability, preliminary antitumor activity, as well as pharmacokinetics (PK) and pharmacodynamics of ...

New Brunswick, NJPHASE1429 participantsExelixis

View Study Details

NCT06033599Recruiting

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake...

New Brunswick, NJPHASE3420 participantsRutgers, The State University of New Jersey

View Study Details

NCT06385080Recruiting

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer

The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in...

New Brunswick, NJPHASE1287 participantsJanssen Research & Development, LLC

View Study Details

NCT06004245Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

This is a first-in-human, Phase I, open-label, multicenter, dose-escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumo...

New Brunswick, NJPHASE1280 participantsVividion Therapeutics, Inc.

View Study Details

NCT07169760Recruiting

R61/33 - VR Study Phase 4

The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity...

New Brunswick, NJPHASE4252 participantsRutgers, The State University of New Jersey

View Study Details

NCT06051890Recruiting

Assessing Optimal XRB Initiation Points in Jail

This application describes a 3-year, randomized controlled trial. Eligible, consenting adults (N=200) with existing sublingual buprenorphine (SLB) prescriptions who enter Middlesex County House of Cor...

New Brunswick, NJPHASE4200 participantsNYU Langone Health

View Study Details

NCT07080242Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroen...

New Brunswick, NJPHASE1120 participantsSystImmune Inc.

View Study Details

NCT06028074Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

GIM-122 is a first-in-class, humanized immunoglobulin G1 kappa dual functioning monoclonal antibody (DFA). This phase 1 / 2 study plans to evaluate the safety, tolerability, pharmacokinetics and clini...

New Brunswick, NJPHASE1111 participantsGeorgiamune Inc

View Study Details

NCT06503614Recruiting

A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

This is a phase 2 open-label two cohort study of durvalumab plus monalizumab in patients with BCG-unresponsive or BCG-exposed CIS NMIBC. Arm A will enroll 43 participants who have cancer in situ (CIS)...

New Brunswick, NJPHASE260 participantsJohn Sfakianos

View Study Details

About Alzheimers Disease Clinical Trials in New Brunswick

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 12 alzheimers disease clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 3,559 participants. Research is being sponsored by Photocure, Genentech, Inc., Rutgers, The State University of New Jersey and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in New Brunswick — FAQ

Are there alzheimers disease clinical trials in New Brunswick?

Yes, there are 12 alzheimers disease clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Brunswick?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.

Are clinical trials in New Brunswick free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 12 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 17, 2026 from ClinicalTrials.gov